Parametric Portfolio Associates’s Affimed AFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$821K Sell
18,778
-1,285
-6% -$55.9K ﹤0.01% 2866
2021
Q4
$1.11M Buy
20,063
+1,391
+7% +$85.9K ﹤0.01% 2738
2021
Q3
$1.15M Sell
18,672
-11,186
-37% -$736K ﹤0.01% 2737
2021
Q2
$2.54M Buy
29,858
+9,357
+46% +$854K ﹤0.01% 2303
2021
Q1
$1.62M Buy
20,501
+9,069
+79% +$589K ﹤0.01% 2913
2020
Q4
$665K Buy
11,432
+2,847
+33% +$134K ﹤0.01% 3237
2020
Q3
$291K Sell
8,585
-793
-8% -$30K ﹤0.01% 3498
2020
Q2
$433K Buy
9,378
+4,683
+100% +$130K ﹤0.01% 3339
2020
Q1
$74K Buy
4,695
+1,950
+71% +$46.4K ﹤0.01% 3779
2019
Q4
$75K Sell
2,745
-663
-19% -$17.7K ﹤0.01% 3895
2019
Q3
$100K Buy
3,408
+1,969
+137% +$58.6K ﹤0.01% 3832
2019
Q2
$41K Buy
+1,439
New +$48.5K ﹤0.01% 3920

Other funds holding AFMD

Parametric Portfolio Associates's AFMD Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Affimed (AFMD) stake by 6.4% in Q1 2022, selling an estimated $55.9K and leaving 18,778 shares worth $821K. The position accounts for ﹤0.01% of the portfolio, ranked #2866.

Parametric Portfolio Associates first reported a position in AFMD in Q2 2019 and has held it in 12 quarters since. The position peaked at $2.54M in Q2 2021. 118 funds tracked by Wall St. Rank hold AFMD as of Q1 2022.

  • Parametric Portfolio Associates held 18,778 shares of Affimed worth $821K as of Q1 2022.
  • Parametric Portfolio Associates sold 1,285 Affimed shares in Q1 2022, an estimated $55.9K.
  • Affimed made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2866 holding.
  • Parametric Portfolio Associates first reported a position in Affimed in Q2 2019 and has held it in 12 quarters since.
  • Parametric Portfolio Associates's Affimed position peaked at $2.54M in Q2 2021.
  • 118 funds tracked by Wall St. Rank held Affimed as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.